uniQure
QURE
#5325
Rank
S$2.08 B
Marketcap
S$30.00
Share price
0.39%
Change (1 day)
-57.28%
Change (1 year)

uniQure (QURE) - Cash on Hand

Cash on Hand as of June 2026 : S$1.03 Billion

According to uniQure's latest financial reports the company has S$1.03 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

uniQure - Cash on Hand chart (from 2012 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31S$0.79 B60%
2024-12-31S$0.49 B-38.78%
2023-12-31S$0.81 B72.52%
2022-12-31S$0.47 B-37.1%
2021-12-31S$0.75 B132.08%
2020-12-31S$0.32 B-36.38%
2019-12-31S$0.50 B58.72%
2018-12-31S$0.32 B50.55%
2017-12-31S$0.21 B11.16%
2016-12-31S$0.19 B-38.83%
2015-12-31S$0.31 B266.62%
2014-12-31S$85.51 M105.28%
2013-12-31S$41.65 M9693.51%
2012-12-31S$0.42 M-76.96%
2011-12-31S$1.84 M-93.97%
2010-12-31S$30.59 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
S$17.89 B 1,626.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$9.26 B 794.38%๐Ÿ‡ซ๐Ÿ‡ท France
Sangamo Therapeutics
SGMO
S$35.27 M-96.60%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
S$0.10 B-90.28%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$1.11 B 7.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
S$2.17 B 109.40%๐Ÿ‡บ๐Ÿ‡ธ USA